Matt Calistri | Vice President of Corporate Strategy and Investor Relations |
Tony Coles | Chairperson and Chief Executive Officer |
Ray Sanchez | Chief Medical Officer |
John Renger | Chief Scientific Officer |
Mark Bodenrader | Interim Chief Financial Officer |
A. Ceesay | President |
Cory Kasimov | JPMorgan |
Michael Yee | Jefferies |
Paul Matteis | Stifel |
Douglas Tsao | H.C. Wainwright |
Madhu Kumar | Goldman Sachs |
Won Jung | Morgan Stanley |
Esther Hong | Berenberg |
Good morning and welcome to the Cerevel Therapeutics first-quarter 2022 financial results conference call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the Q&A portion of the call. Please note that this call may be recorded. I will now hand the call over to Mr.